E. Davis - Feb 23, 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
CEO and President, Director
Signature
Sean D. Mersten, Attorney in Fact for James E. Davis
Stock symbol
DGX
Transactions as of
Feb 23, 2024
Transactions value $
$858,262
Form type
4
Date filed
2/27/2024, 04:35 PM
Previous filing
Feb 23, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $1.67M +13.4K +10.79% $125.02 138K Feb 23, 2024 Direct F1
transaction DGX Common Stock Tax liability -$816K -6.53K -4.75% $125.02 131K Feb 23, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d).
F2 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.